The Computerized Retraining and Functional Treatment - Group Intervention
CRAFT-G
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this clinical trial is to examine the efficacy of a novel, remotely-applied group intervention, Cognitive Retraining and Functional Treatment Group (CRAFT-G), designed to improve cognitive function, mental health and functional outcome in breast cancer survivors (BCS) with Cancer-Related Cognitive Impairment (CRCI) while simultaneously collecting data on the barriers and facilitators of implementation in clinical settings. The main question it aims to answer is: We hypothesize that participants receiving CRAFT-G will show gains in mental health, cognitive and daily function, and that the CRAFT-G benefits will endure for three months following treatment completion. Participants assigned to the waitlist control will crossover to the CRAFT-G intervention group after 6 weeks. Participants will ask to complete CRAFT-G intervention, which include:
- Six remote group sessions (1.5hr each)
- Between the sessions, participants will be guided to complete CRCI-specific computerized cognitive training (CCT) 3 times per week delivered using dedicated app.
- Psychoeducation materials Assessment will take place in 3 time points: before intervention (frontal meeting for baseline assessment), post intervetion and 3 months post intervention. The study will be conducted to explore implementation barriers and facilitators. This will be done by endline qualitative interviews with the participants' research group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2025
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
May 18, 2026
May 1, 2026
1.9 years
May 11, 2026
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Functional Assessment of Cancer Therapy - Cognition (FACT COG)
A self-report questionnaire for cancer patients capturing subjective experiences of cognitive decline. The participants are asked to rate the items on a five-level scale ranging from 0="never" or "not at all" to 4="several times a day" or "very much;" higher scores represent better perceived cognitive function and QoL. Minimal clinically important difference (MCID) for the FACT-Cog was found to range from +4.7% to +7.2% for improvement (Liang et al., 2019), and -6.9 to -10.6 points for reduction.
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
The Canadian Occupational Performance Measure (COPM)
A semi-structured interview used to assess the self-perception of clients' performance and satisfaction with performance in individual functional goals. The goals are quantified by rating importance, performance, and satisfaction on a 10-point Likert scale. A higher score indicates a greater outcome. A two-point difference between measurements taken at different time points is considered the Minimal Clinically Important Difference (MCID).
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
The Performance Quality Rating Scale (PQRS)
The PQRS is used in conjunction with the COPM, to compliment the client's perceived performance with actual performance or client's self-report performance of the client-selected goal. The researcher or clinician rates the performance on a scale of 1 (the skill is not done well) to 10 (the skill is performed very well). A two-point difference between measurements taken at different time points is considered the Minimal Clinically Important Difference (MCID).
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
Secondary Outcomes (6)
Online cognitive assessment battery
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
EuroQol Five-Dimension, Five-Level (EQ-5D-5L)
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
Goal Specific Hope Scale (GSHS)
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
The Depression, Anxiety, and Stress Scale - 21 (DASS-21)
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
The Self-Compassion Scale - Short Form (SCS-SF)
At baseline assessment and will be repeated post-intervention at week 6, and at follow-up (week 12).
- +1 more secondary outcomes
Other Outcomes (2)
A demographic and medical questionnaire was developed and designed for the study to collect descriptive personal, demographic, and medical information.
At baseline assessment
A questionnaire aimed at assessing their satisfaction with the CRAFT-G.
Post intervention at week 6
Study Arms (2)
Cognitive Retraining and Functional Treatment Group (CRAFT-G) intervention
EXPERIMENTALCRAFT-G include six remote group sessions (1.5hr each) led by an occupational therapist. The content of the meetings will be adapted from the cognitive orientation to occupational performance (CO-OP) approach accompanied with relevant psychoeducation materials. Between the sessions, participants will be guided to complete Cancer-related cognitive impairment (CRCI)-specific computerized cognitive training (CCT) 3 times per week delivered using dedicated app. In addition, psychoeducation materials will be delivered during group sessions.
Computerized cognitive training group
EXPERIMENTALParticipants opting for the cognitive training group will undergo computerized cognitive training (CCT), similar in content and duration to that provided in the CRAFT-G intervention group.
Interventions
CRAFT-G include six remote group sessions (1.5hr each) led by an occupational therapist. The content of the meetings will be adapted from the cognitive orientation to occupational performance (CO-OP) approach accompanied with relevant psychoeducation materials. Between the sessions, participants will be guided to complete Cancer-related cognitive impairment (CRCI)-specific computerized cognitive training (CCT) 3 times per week delivered using dedicated app. In addition, psychoeducation materials will be delivered during group sessions.
Participants opting for the cognitive training group will undergo computerized cognitive training (CCT), similar in content and duration to that provided in the CRAFT-G intervention group.
Eligibility Criteria
You may qualify if:
- women, 18 years old and older
- A subjective concern about declines in cognitive functioning related to a diagnosis of breast cancer and/or cancer related treatment
- Objective cognitive decline with no dementia (19\<MOCA)
- months or more after completion of an active treatment for cancer
- Daily access to the internet and sufficient basic skills to operate a computer
You may not qualify if:
- Unstable psychiatric or other health condition according to participants' self-report and medical file.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- Israel Cancer Associationcollaborator
- Hebrew University of Jerusalemcollaborator
Study Sites (1)
Hadassah Medical Care
Jerusalem, Israel
Related Publications (1)
Maeir T, Makranz C, Peretz T, Odem E, Tsabari S, Nahum M, Gilboa Y. Cognitive Retraining and Functional Treatment (CRAFT) for adults with cancer related cognitive impairment: a preliminary efficacy study. Support Care Cancer. 2023 Feb 7;31(3):152. doi: 10.1007/s00520-023-07611-y.
PMID: 36746805BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 18, 2026
Study Start
November 16, 2025
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
May 18, 2026
Record last verified: 2026-05